My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Nvidia Targets $1 Trillion Revenue, Backed By...
Josh D'Amaro Takes The Helm At Disney, Analys...
Microsoft Unifies AI Division To End Copilot...
Boeing Seen Steady On Production, Defense Ups...
Apple Stock Is Already A Portfolio Staple — A...
Caterpillar's Secret Weapon: Data Centers Cou...
Nvidia's Jensen Huang Wants To 'Die On The Jo...
Macy's, Bloomingdale's Deliver Record Holiday...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    GUGGENHEIM STRATEGIC OPPORTUNITIES (NYSE: GOF)

    Overview
    current price
    $11.04
    $11.04
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    11.04
    open
    0.00
    volume
    0.02 M
    30d. avg volume.
    1.60 M
    1 day
    0.00 - 0.00
    52 weeks
    10.91 - 15.93
    p/e
    0.00
    beta
    0.6115
    market cap
    1.79 B
    dividend yield
    19.79%
    Industry
    -
    GOF by TradingView
    News and Commentary
    Regeneron Antibody Therapy Showing Promise A coronavirus antibody treatment being tested by Regeneron
    IPO Update: Casper Sleep Invests in the "Sleep Economy" Well-know private mattress maker Casper Sleep filed its S-1 paperwork with the U.S. Securities and Exchange Commission on Friday. The company views itself as a major player in th...
    StockTwits
    StockTwits
    Most Shared
    AI Giants Are Buying The World's Memory, And You're Getting The Bill
    Tesla's FSD Safety Metrics 'Sharply Deteriorating,' Says Analyst
    Trump's Global Tariff Kicks In At 10% From Tuesday, Instead Of 15%
    Most Popular
    AI Is Rewriting Market Leadership — Goldman Says HALO Stocks Are The Big Winners
    AI Giants Are Buying The World's Memory, And You're Getting The Bill
    Burger King Tests AI Tracking Employee Courtesy: Will Extra 'Please' And 'Thank Yous' Lift The Stock?
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Coronavirus Impact
    Tesla
    Google
    Covid-19
    China
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?